These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 13796178)

  • 1. Acquired and crossed tolerance to mescaline, LSD-25, and BOL-148.
    BALESTRIERI A; FONTANARI D
    AMA Arch Gen Psychiatry; 1959 Sep; 1():279-82. PubMed ID: 13796178
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of psilocin with psilocybin, mescaline and LSD-25.
    WOLBACH AB; MINER EJ; ISBELL H
    Psychopharmacologia; 1962; 3():219-23. PubMed ID: 14007905
    [No Abstract]   [Full Text] [Related]  

  • 3. JB 329 degrees--a new spychotomimetic, its antagonism by tetrahydroaminacrin and its comparison with LSD, mescaline and sernyl.
    GERSHON S; OLARIU J
    J Neuropsychiatr; 1960; 1():283-92. PubMed ID: 13827606
    [No Abstract]   [Full Text] [Related]  

  • 4. Mescaline, LSD, psilocybin, and personality change.
    UNGER SM
    Psychiatry; 1963 May; 26():111-25. PubMed ID: 13995386
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle.
    Geyer MA; Petersen LR; Rose GJ; Horwitt DD; Light RK; Adams LM; Zook JA; Hawkins RL; Mandell AJ
    J Pharmacol Exp Ther; 1978 Dec; 207(3):837-47. PubMed ID: 731434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopharmacological studies of lysergic acid diethylamide (LSD-25) intoxication; effects of premedication with BOL-128 (2-bromo-d-lysergic acid diethylamide), mescaline, atropine, amobarbital, and chlorpromazine.
    CLARK LD; BLISS EL
    AMA Arch Neurol Psychiatry; 1957 Dec; 78(6):653-5. PubMed ID: 13478222
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of the hallucinogenic drugs LSD-25 and mescaline on the electroretinogram.
    APTER JT; PFEIFFER CC
    Ann N Y Acad Sci; 1957 Mar; 66(3):508-13; discussion, 513-4. PubMed ID: 13425239
    [No Abstract]   [Full Text] [Related]  

  • 8. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EFFECT OF MESCALINE, LYSERGIC ACID DIETHYLAMIDE AND PSILOCYBIN ON COLOR PERCEPTION.
    HARTMAN AM; HOLLISTER LE
    Psychopharmacologia; 1963 Aug; 4():441-51. PubMed ID: 14048565
    [No Abstract]   [Full Text] [Related]  

  • 10. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross tolerance between mescaline and LSD-25, with a comparison of the mescaline and LSD reactions.
    WOLBACH AB; ISBELL H; MINER EJ
    Psychopharmacologia; 1962 Mar; 3():1-14. PubMed ID: 14007904
    [No Abstract]   [Full Text] [Related]  

  • 12. LSD and other related hallucinogens elicit myoclonic jumping behavior in the guinea pig.
    Carvey P; Nausieda P; Weertz R; Klawans H
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):199-210. PubMed ID: 2748860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural effects of some derivatives of amphetamine and LSD and their significance.
    Smythies JR; Beaton J; Benington F; Morin RD
    Nature; 1970 May; 226(5246):644-5. PubMed ID: 5444927
    [No Abstract]   [Full Text] [Related]  

  • 14. The pharmacology of mescaline and D-lysergic acid diethylamide (LSD).
    KOELLE GB
    N Engl J Med; 1958 Jan; 258(1):25-32. PubMed ID: 13493730
    [No Abstract]   [Full Text] [Related]  

  • 15. Behavioral effects of intracerebroventricular administration of LSD, DOM, mescaline or lisuride.
    Mokler DJ; Rech RH
    Pharmacol Biochem Behav; 1984 Aug; 21(2):281-7. PubMed ID: 6483939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HISTOCHEMICAL STUDIES ON THE MECHANISM OF ACTION OF THE HALLUCINOGENS D-LYSERGIC ACID DIETHYLAMIDE TARTRATE (LSD-25) AND D-2-BROMO-LYSERGIC ACID TARTRATE (BOL-148) IN RAT BRAIN.
    SHANTHAVEERAPPA TR; NANDY K; BOURNE GH
    Acta Neuropathol; 1963 Sep; 3():29-39. PubMed ID: 14197655
    [No Abstract]   [Full Text] [Related]  

  • 17. Modification of the pigment screening of the frog retina following administration of neuroactive drugs.
    Kemali M; Milici N; Kemali D
    Exp Eye Res; 1983 Nov; 37(5):493-8. PubMed ID: 6142827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysergic acid diethylamide (LSD) and JB 318: a comparison of two hallucinogens. II. An exploratory study.
    LEBOVITS BZ; VISOTSKY HM; OSTFELD AM
    Arch Gen Psychiatry; 1960 Aug; 3():176-87. PubMed ID: 14415047
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence for the action of d-lysergic acid diethylamide, mescaline and bufotenine on 5-hydroxytryptamine receptors in umbilical vasculature.
    Dyer DC
    J Pharmacol Exp Ther; 1974 Feb; 188(2):336-41. PubMed ID: 4359552
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe aggression in rats induced by mescaline but not other hallucinogens.
    Sbordone RJ; Wingard JA; Gorelick DA; Elliott ML
    Psychopharmacology (Berl); 1979; 66(3):275-80. PubMed ID: 119274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.